Europe Dermal Fillers Market Research Report Forecast to 2032
Dermal filler is a gel-like substance that is injected underneath the skin to restore lost volume, often creases and smooth lines or enhance facial contours. Dermal fillers usage has rapidly grown in recent years because of various offerings in the enhancing aesthetic and rejuvenate improvements that were previously only achievable with surgeries. These are becoming very popular for facial rejuvenation methods. Being minimally invasive dermal filler shows instantaneous results in cosmetic volume replacement therapies.
Dermal fillers can be defined as soft tissue fillers injected into the skin for the restoration of smooth appearance and the reduction of wrinkles and other signs of the aging process. The rapidly expanding range of dermal filler products and their increased benefits are fueling the preference rates of dermal fillers among medical professionals as well as patients. The growing demand for facial aesthetics, increasing inclination towards the use of dermal fillers, a rise in the number of plastic surgeons performing cosmetic surgeries, and the decreased procedural cost of dermal fillers in comparison to the cosmetic surgeries are driving the dermal fillers market. However, the side-effects associated with such facial injectables, coupled with the increasing black market for dermal fillers, and emergence of COVID-19 coronavirus is likely to curb the growth of the dermal fillers market. Nevertheless, the rise in the number of clinical trial studies for increasing efficiency rates of dermal fillers will create lucrative opportunities for the growth of the market during the assessment period.
Market SegmentationBased on type, the Europe dermal fillers market has been segmented into botulinum toxin, calcium hydroxylapatite, hyaluronic acid, polyalkylimide, poly-L-lactic acid, polymethyl-methacrylate microspheres (PMMA), and others.
Based on product, the Europe dermal fillers market has been segmented into biodegradable, non-biodegradable, synthetic neurotoxins.
On the basis of application, the Europe dermal fillers market has been segmented into facial line correction, face lift, lip enhancement, facial scars, nasolabial folds, and others.
Based on country, the Europe dermal filler market has been segmented into Germany, France, UK, Italy, Spain, Denmark, Finland, Iceland, Norway, Sweden, and Rest of Europe. Germany accounted for the largest market share in 2022. However, France is projected to grow at fastest growing during the forecast period.
Major PlayersThe key market players are Merz Pharma GmbH & Co. KGaA, Sinclair Pharma, Ipsen SA (Ipsen), ADODERM GmbH, BioScience GmbH, Allergan Inc. (Allergan), Galderma develops aesthetics, Teoxane, Dr. Korman, and Medytox.